elranatamab
pfizer
['mmsm', 'elranatamab']
elranatamab data looks very encouraging but 5% rate of pjp pna and also cmv reactivation/infection is not insignificant. seems to be a class effect with bcma bispecifics #mmsm #ash2022 
Hematologist/Oncologist | Myeloma Physician/Clinical Investigator | @danafarber @harvardmed #multiplemyeloma #mmsm